Cargando…

Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications

Background: The most frequent inflammatory skin diseases are psoriasis, atopic dermatitis, hidradenitis suppurativa, and acne. Their management is challenging for dermatologists since their relapsing chronic clinical course is associated with a great impact on quality of life. Nevertheless, the rece...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marasca, Claudio, Annunziata, Maria Carmela, Camela, Elisa, Di Guida, Adriana, Fornaro, Luigi, Megna, Matteo, Napolitano, Maddalena, Patruno, Cataldo, Potestio, Luca, Fabbrocini, Gabriella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950226/ https://www.ncbi.nlm.nih.gov/pubmed/35329838 http://dx.doi.org/10.3390/jcm11061511

Ejemplares similares

Teledermatology: A useful tool also after COVID‐19 era?
por: Megna, Matteo, et al.
Publicado: (2022)

The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review
por: Ruggiero, Angelo, et al.
Publicado: (2022)

Reply to Borgia et al. Comment on “Marasca et al. Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications. J. Clin. Med. 2022, 11, 1511”
por: Potestio, Luca, et al.
Publicado: (2022)

Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future?
por: Martora, Fabrizio, et al.
Publicado: (2023)

May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions?
por: Marasca, Claudio, et al.
Publicado: (2020)

Long‐term results of teledermatology for acne patients during COVID‐19 pandemic
por: Villani, Alessia, et al.
Publicado: (2022)

Letter to the editor regarding article “Yalici‐Armagan B, Tabak GH, Dogan‐Gunaydin S, Gulseren D, Akdogan N, Atakan N. Treatment of psoriasis with biologics in the early COVID‐19 pandemic: A study examining patient attitudes toward the treatment and disease course. J Cosmet Dermatol. 2021;00:1–5”
por: Potestio, Luca, et al.
Publicado: (2021)

Treatment of Atopic Dermatitis with Biologic Drugs
por: Fabbrocini, Gabriella, et al.
Publicado: (2018)

Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge
por: Ruggiero, Angelo, et al.
Publicado: (2022)

Risankizumab treatment in psoriasis patients who failed anti‐IL17: A 52‐week real‐life study
por: Megna, Matteo, et al.
Publicado: (2022)

Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: Results from an Italian single‐center retrospective study in a real‐life setting
por: Megna, Matteo, et al.
Publicado: (2022)

Letter to the editor regarding the article “Oguz Topal I, Kara Polat A, Zindancı İ, et al. Adherence to systemic therapy in patients with psoriasis during the COVID‐19 pandemic: A multicenter study. J Cosmet Dermatol. 2021;10.1111/jocd.14610.”
por: Potestio, Luca, et al.
Publicado: (2022)

Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience
por: Martora, Fabrizio, et al.
Publicado: (2023)

Efficacy and Safety of Anti-TNF Biosimilars for Psoriasis in Pediatric and Geriatric Populations: A 72-Week Real-Life Study
por: Megna, Matteo, et al.
Publicado: (2022)

Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab
por: Megna, Matteo, et al.
Publicado: (2022)

A case of pediatric psoriasis successfully and rapidly treated with ixekizumab
por: Megna, Matteo, et al.
Publicado: (2021)

The Use of JAK/STAT Inhibitors in Chronic Inflammatory Disorders
por: Caiazzo, Giuseppina, et al.
Publicado: (2023)

The Role of Thermal Water in Chronic Skin Diseases Management: A Review of the Literature
por: Cacciapuoti, Sara, et al.
Publicado: (2020)

Onset of vitiligo in a psoriasis patient on ixekizumab
por: Marasca, Claudio, et al.
Publicado: (2021)

How Adalimumab Impacts Antibiotic Prescriptions in Patients Affected by Hidradenitis Suppurativa: A 1-Year Prospective Study and Retrospective Analysis
por: Martora, Fabrizio, et al.
Publicado: (2023)

Skin rashes after SARS‐CoV‐2 vaccine: which relationship, if any?
por: Patruno, Cataldo, et al.
Publicado: (2021)

Secukinumab and hidradenitis suppurativa: Friends or foes?
por: Marasca, Claudio, et al.
Publicado: (2019)

Adalimumab biosimilar in a pediatric patient: Clinical and in vivo reflectance confocal microscopy evaluation
por: Megna, Matteo, et al.
Publicado: (2022)

Towards Personalized Medicine in Psoriasis: Current Progress
por: Camela, Elisa, et al.
Publicado: (2022)

A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab
por: Megna, Matteo, et al.
Publicado: (2022)

Teledermatology in the management of hidradenitis suppurativa: Should we improve this service?
por: Ruggiero, Angelo, et al.
Publicado: (2022)

Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment
por: Napolitano, Maddalena, et al.
Publicado: (2017)

Herpes zoster and alopecia areata following mRNA BNT162b2 COVID‐19 vaccine: Controversial immune effects
por: Martora, Fabrizio, et al.
Publicado: (2022)

Reply: Potential role of Janus kinase inhibitors in COVID-19
por: Napolitano, Maddalena, et al.
Publicado: (2020)

The hidden sentinel of the skin: An overview on the role of interleukin-13 in atopic dermatitis
por: Napolitano, Maddalena, et al.
Publicado: (2023)

Role of Aryl Hydrocarbon Receptor Activation in Inflammatory Chronic Skin Diseases
por: Napolitano, Maddalena, et al.
Publicado: (2021)

New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge
por: Potestio, Luca, et al.
Publicado: (2023)

Biologics for the Management of Erythrodermic Psoriasis: An Updated Review
por: Potestio, Luca, et al.
Publicado: (2023)

Use of Biological Therapies for the Management of Pustular Psoriasis: A New Era?
por: Megna, Matteo, et al.
Publicado: (2023)

Prevalence of Chronic Inducible Urticaria in Elderly Patients
por: Napolitano, Maddalena, et al.
Publicado: (2021)

May IL-17 have a role in COVID-19 infection?
por: Megna, Matteo, et al.
Publicado: (2020)

A Case of Ofuji Disease Successfully Treated with the Combination of Low-Dose Indomethacin and Topical Tacrolimus
por: Marasca, Claudio, et al.
Publicado: (2020)

COVID-19, quarantine, and atopic dermatitis
por: Patruno, Cataldo, et al.
Publicado: (2020)

Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection
por: Megna, Matteo, et al.
Publicado: (2022)

Urticaria relapse after mRNA COVID‐19 vaccines in patients affected by chronic spontaneous urticaria and treated with antihistamines plus omalizumab: A single‐center experience
por: Picone, Vincenzo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_go0bub4grqeji62t6t8k6n9idc